Cellectar Biosciences Shares Rise 10% After Being Granted Four Patents
By Chris Wack Cellectar Biosciences shares were up 10% to $2.91 on Monday after the company said it secured four patents across Europe, Australia and Canada,...
Chris Wack Cellectar Biosciences Australian Patent Office European Patent Office Canadian Intellectual Property Office Phospholipid Drug Conjugate
Source: marketwatch.com